Carvalho, Thiago
Krammer, Florian http://orcid.org/0000-0003-4121-776X
Iwasaki, Akiko http://orcid.org/0000-0002-7824-9856
Article History
Accepted: 17 February 2021
First Online: 15 March 2021
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines, naming F.K. as co-inventor. The authors would also like to note the following, which could be perceived as a conflict of interest for F.K.: he has previously published work on influenza virus vaccines with S. Gilbert (University of Oxford), has consulted for Curevac, Merck and Pfizer (before 2020), is currently consulting for Avimex (Mexico) and Seqirus (Australia), his laboratory is collaborating with Pfizer on animal models of SARS-CoV-2, his laboratory is collaborating with N. Pardi at the University of Pennsylvania on mRNA vaccines against SARS-CoV-2, his laboratory was working in the past with GlaxoSmithKline on the development of influenza virus vaccines, and two of his mentees have recently joined Moderna. A.I. served as a consultant for Adaptive Biotechnologies. T.C. declares no competing interests.
Free to read: This content has been made available to all.